Clinical Trials on 肝炎,自身免疫 in Germany
总计1622个结果
-
Hannover Medical School招聘中
-
Novartis Pharmaceuticals完全的
-
sigma-tau i.f.r. S.p.A.SciClone Pharmaceuticals完全的
-
HepNet Study House, German LiverfoundationHannover Medical School完全的
-
ANRS, Emerging Infectious DiseasesEUCLID Clinical Trial Platform招聘中乙型肝炎,慢性法国, 德国, 意大利, 西班牙
-
Gilead Sciences完全的丙型肝炎病毒感染法国, 奥地利, 德国, 意大利
-
Hannover Medical SchoolGilead Sciences; HepNet Study House, German Liverfoundation; German Center for Infection Research完全的
-
University Hospital, BonnDr. Axel Baumgarten, Berlin; Dr. Christoph Stephan, Frankfurt/M; Dr. Stefan Esser, Essen; Dr. Keikawus... 和其他合作者撤销
-
Enanta Pharmaceuticals, Inc完全的
-
Johannes Gutenberg University MainzRoche Pharma AG完全的
-
Charite University, Berlin, GermanyLudwig-Maximilians - University of Munich完全的
-
Arrowhead Pharmaceuticals终止
-
Universitätsklinikum Hamburg-EppendorfBristol-Myers Squibb完全的
-
Janssen Pharmaceutica N.V., Belgium完全的
-
Debiopharm International SA完全的
-
Gilead Sciences完全的
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of Alexion终止
-
Tibotec Pharmaceuticals, Ireland完全的
-
Novartis Pharmaceuticals完全的慢性丙型肝炎基因型 1 复发比利时, 美国, 德国, 西班牙, 波多黎各, 台湾, 澳大利亚
-
HepNet Study House, German LiverfoundationGilead Sciences; Hannover Medical School完全的
-
Vir Biotechnology, Inc.招聘中
-
Janssen Sciences Ireland UC完全的
-
University Hospital FreiburgBiosyn完全的肝硬化 | 癌,肝细胞癌 | 丙型肝炎德国
-
Janssen-Cilag International NV完全的
-
Gilead Sciences完全的
-
Bristol-Myers Squibb终止
-
Universitätsklinikum Hamburg-Eppendorf未知